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Abstract
The Caribbean and Central America are among the regions with highest HIV-1B prevalence worldwide. Despite of this high
virus burden, little is known about the timing and the migration patterns of HIV-1B in these regions. Migration is one of the
major processes shaping the genetic structure of virus populations. Thus, reconstruction of epidemiological network may
contribute to understand HIV-1B evolution and reduce virus prevalence. We have investigated the spatio-temporal
dynamics of the HIV-1B epidemic in The Caribbean and Central America using 1,610 HIV-1B partial pol sequences from 13
Caribbean and 5 Central American countries. Timing of HIV-1B introduction and virus evolutionary rates, as well as the
spatial genetic structure of the HIV-1B populations and the virus migration patterns were inferred. Results revealed that in
The Caribbean and Central America most of the HIV-1B variability was generated since the 80 s. At odds with previous data
suggesting that Haiti was the origin of the epidemic in The Caribbean, our reconstruction indicated that the virus could
have been disseminated from Puerto Rico and Antigua. These two countries connected two distinguishable migration areas
corresponding to the (mainly Spanish-colonized) Easter and (mainly British-colonized) Western islands, which indicates that
virus migration patterns are determined by geographical barriers and by the movement of human populations among
culturally related countries. Similar factors shaped the migration of HIV-1B in Central America. The HIV-1B population was
significantly structured according to the country of origin, and the genetic diversity in each country was associated with the
virus prevalence in both regions, which suggests that virus populations evolve mainly through genetic drift. Thus, our work
contributes to the understanding of HIV-1B evolution and dispersion pattern in the Americas, and its relationship with the
geography of the area and the movements of human populations.
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Introduction
At the end of 2011, 34 million people were estimated to be
living with HIV worldwide, of which 2.5 million were new
infections [1,2]. For the last decade, The Caribbean has been
reported to have the second highest regional HIV prevalence (1%),
with 230.000 people living with AIDS. In spite of its geographical
proximity, Central America has a considerably lower HIV
prevalence (0.5%), with 1.4 million people infected by HIV [2].
Given these numbers, HIV remains a major health concern in
Central America and The Caribbean.
Increasing effort has been devoted to gather information on the
HIV epidemiology in The Caribbean and Central America. In
these regions, the burden of HIV ranges from very low prevalence
in Cuba (0.1%) or Mexico (0.3%) to a significant 2.3% in Belize or
3% in Bahamas, with prevalence of up to 5% in Jamaica and 7%
in Santa Lucia for specific collectives [1]. This large variation in
HIV prevalence might be explained by differences in social and
geographical characteristics of human populations such as: (i) the
studied populations, (ii) the main mode of virus transmission, and
(iii) the access to antiretroviral therapy [2]. For instance, HIV
prevalence in female sex workers varies from 2% in the Dominican
Republic to 12% in some areas of Mexico [2]; and it has been
estimated that more than one quarter of the 2 million injecting
drug users in Latin America might be living with HIV [3]. In
addition, the main mode of HIV transmission in The Caribbean is
believed to be unprotected sex between men and women, but most
HIV epidemics in Central America are associated with networks of
men who have sex with men [4]. Exceptions to this rule are
Bermuda and Puerto Rico where unsafe injecting drug use
significantly contributes to the spread of HIV [2]. Finally,
antiretroviral therapy (ARV) coverage largely varies depending
on the country, reaching more than 80% of the eligible population
in Cuba, but less than 40% in Panama [1,2].
Disease epidemiology may influence the genetic structure of the
virus populations [5,6]. However, knowledge on the evolutionary
history, the population dynamics and the genetic structure of HIV
in Central America and The Caribbean is scarcer than in other
parts of the world [7]. HIV-1 subtype B (HIV-1B) is the
predominant variant in these regions [8–12], with the exception
of Cuba [13,14]. The few analyses of the genetic structure of the
HIV-1B population in Central America, limited to individual
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countries, have not reported genetic differences with the HIV-1B
populations of other geographical regions [8,9,15]. On the other
hand, phylogenetic analyses of multinational sequences have
revealed that Caribbean HIV-1B isolates are genetically distinct
from the subtype B pandemic clade [12,16,17]. These results have
been associated with geographical and social characteristics of the
human population. For instance, it has been proposed that this
genetic compartmentalization of the Caribbean population is the
result of selective pressures for adaptation to heterosexual
transmission mode on the basis of the lack of association between
the HIV-1B phylogeny and the geographical origin of each
sequence [12]. However, these analyses were performed using a
limited number of sequences (n = 67) and countries (n = 4), and no
quantitative approach was used.
Another underexplored aspect of the HIV-1B epidemic in
Central America and The Caribbean, also linked to disease
epidemiology, is the migration pattern of the virus [16,17].
Migration is one of the major processes shaping the genetic
structure of virus populations [18], and reconstructing dispersion
routes provides fundamental understanding of the evolutionary
dynamics of virus epidemics [19]. It is generally accepted that
Haiti is the origin of the HIV-1B pandemic, which seems to be
associated with human migration patterns [16,17]. Despite the
importance of The Caribbean in the HIV-1B epidemic, to date
there has been no attempt to reconstruct the evolutionary history
or the migration patterns of the virus in this region. It could be
hypothesized that Haiti was also the origin of the epidemic within
The Caribbean islands. However, Gilbert et al. [16] found
evidence that most of the initial movements of HIV-1B out of
Haiti resulted in dead-end infections, which raises the possibility of
a different origin for The Caribbean epidemic. Moreover, the
Haitian sequences seems not to fall in the basal positions of
phylogenetic trees when only Caribbean sequences are considered
[12]. Accordingly, some authors have argued that the introduction
of HIV-1B in The Caribbean that caused the pandemic in the
region might have come from North America [20,21]. Thus, the
origin and spread of the epidemic in the central region of the
Americas is still unclear.
The objective of the current study was to investigate: i) the time
scale of the HIV-1B evolution; ii) the genetic structure of HIV-1B
populations; iii) the dispersion patterns that may have led to the
current genetic structure of the HIV-1B populations, and its
possible association with the geography and with human
migrations in Central America and The Caribbean. To address
these issues, we have combined Bayesian phylogenetic reconstruc-
tion techniques on a Coalescence Theory framework, with
classical population genetics methods. These methodologies have
been shown to yield valuable information about HIV-1 popula-
tion-level processes, such as transmission networks [22,23], or
evolutionary dynamics in several geographic regions [24–26].
Using this approach, we present here an analysis of the genetic
structure and a reconstruction of the evolutionary history of HIV-1
subtype B in Central America and The Caribbean, which is the
first of this kind in these geographical regions. Our data provide
insights on migration patterns and evolutionary potential of HIV-
1B, which may help to understand the evolutionary forces shaping
the HIV-1B epidemic in the studied regions, and worldwide.
Materials and Methods
Sequence and Prevalence Data
All available HIV-1B sequences of individual patients from
Central American and Caribbean countries, as well as the year of
sampling of the virus isolate that led to each sequence, were
recovered from Los Alamos National Lab HIV database [10]. No
other HIV-1 subtypes or recombinant variants were considered in
this study. Only countries with at least 4 available polymerase gene
(pol) sequences were retained for analysis. Based on these criteria, a
total of 1,610 HIV-1 partial pol sequences were selected.
Sequences were collected from 774 HIV-1B infected individuals
from five Central American countries between 2001 and 2010,
and from 836 patients from thirteen Caribbean countries between
1996 and 2010. We focused our analysis on a region of the pol gene
comprising the genomic region encoding for the viral protease
(PR) and the fragment coding for the first 334 amino acid residues
of the reverse transcriptase (RT) (1005 nucleotides, positions 2255–
3259 of HXB2 subtype B reference strain, GenBank accession
number K03455), from here on named polp. The countries
included in our analyses with the corresponding number of polp
sequences used are shown in Figure 1. A full list of GenBank
accession numbers, countries of origin, and year of isolation, as
well as the relevant publication associated with each sequence, is
available as supplementary material (Table S1). Sequence
alignments were constructed using MUSCLE 3.7 [27] and
adjusted manually according to the amino acid sequences using
Se-Al [28].
HIV-1B prevalence data in each country was obtained using
previously reported data from 2001 to 2009, the period in which
most of the sequences of our data sets were collected. The
consulted sources reported highly similar prevalence values. Thus,
for our analyses we used those reported by the United Nations
[29,30].
Estimate of Nucleotide Substitution Rates and
Divergence Time
Bioinformatics tools were applied to estimate nucleotide
substitution rates and time to the most recent common ancestor
(TMRCA) in our HIV-1 polp sequence data sets. The presence of
temporal signal in the analyzed data sets is essential to the accurate
estimate of these two parameters. Thus, we first assessed the
strength of temporal signal in the Central American and in the
Caribbean HIV-1 polp data sets. To do so, we constructed
maximum-likelihood (ML) trees inferred with PhyML [31] using
Subtree Pruning Regrafting (SPR) method, incorporating the best-
fitted nucleotide substitution model as determined by jModelTest
0.1.1 [32]. Clock-like behavior of the data was then assessed by
regressing root-to-tip distance in the ML tree against the date of
sampling of each sequence using Path-O-Gen v1.3 [33]. This
analysis effectively provides a measure of the amount of variation
in genetic distances explained by sampling time. To confirm the
temporal signal, the BEAST analyses described below were
repeated on data sets in which sampling times were randomized
so that temporal structure was disrupted. Runs for randomized
data were repeated 10 times.
Rates of nucleotide substitutions per site per year (subs/site/
year), and the TMRCA were estimated for both the Central
American and the Caribbean data sets using the Bayesian Markov
Chain Monte Carlo (MCMC) method available in the BEAST
package v1.6.1 [34]. The best-fit model of nucleotide substitution
in each case was determined using jModeltest. A relaxed
(uncorrelated lognormal) molecular clock and the flexible Bayesian
skyline model as a coalescent prior were also used. In all cases, the
BEAST analyses were run until all relevant parameters converged,
with 10% of the MCMC chains discarded as burn-in. Statistical
confidence in the parameter estimates was represented by values
for the 95% highest probability density (HPD) intervals around the
marginal posterior parameter means. Substitution rates and
TMRCAs were considered to be significantly different if the
HIV Phylogeography in Caribbean/Central America
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mean value of one estimate fell outside of the 95% HPD values of
another (indicating that these rates/TMRCAs were drawn from
different distributions). Maximum clade credibility (MCC) trees,
with Bayesian posterior probability values providing a measure of
statistical support at each node, were also inferred using BEAST.
In these MCC trees, the date of the oldest node defining a cluster
of sequences from a given country was selected as the TMRCA of
that country.
Analysis of Spatial Genetic Structure of the HIV-1B
Populations
We also applied bioinformatics tools designed for comparative
sequence analysis to explore the spatial genetic structure of the
HIV-1B populations in Central America and The Caribbean. We
followed three approaches:
1)) We assessed the degree of association between country of
origin and position of the sequence in the virus phylogenies
using the Parsimony Score [PS, 35], the Association Index
[AI, 36] and the Monophyletic Clade Size [MC, 37] statistics.
PS and AI indicate the degree of phylogenetic clustering of
sequences that come from the same country across the entire
tree. MC assesses the association between country of origin
and the virus phylogeny by estimating the size of the largest
cluster of sequences coming from the same country. These
analyses were performed using the program BaTS [37], which
calculates empirical distributions of these statistics from the
credible sample (posterior distribution) of trees provided by
BEAST. Null distributions for the three statistics were
generated by using 1000 data replications.
2)) We estimated within- and between-countries genetic diversi-
ties, by calculating pairwise distances for each pair of
countries, and using the Tamura-Nei nucleotide substitution
model as implemented in MEGA 5 [38]. Standard errors of
each genetic diversity measure were calculated based on 1000
replicate bootstrap. To determine if genetic diversity values
were significantly different from each other, the 95%
confidence interval (CI) was calculated in each case using
the variance obtained by bootstrap [39] and assuming a
normal distribution. We considered two genetic diversities as
significantly different if the mean value of one estimate fell
outside of the 95% CI of the other.
In addition, we calculated the percentage of the total genetic
diversity explained by the between-countries genetic diversity
using the NST and the FST coefficients. NST was computed
following the expression: , where dST is the between-
countries genetic diversity andpT the total genetic diversity [39].
FST was calculated by Analysis of Molecular Variance (AMOVA),
as implemented in Arlequin v.3.11 [40]. AMOVA was also
utilized to test the differences between nucleotide diversities of the
virus populations in each country. Significance of these differences
was obtained by performing 1000 permutations.
3) We tested the hypothesis of isolation-by-distance [41], which
predicts that the more geographically distant two populations
of any organism are, the more genetically differentiated. We
assessed the relationship between geographic and genetic
distances using Mantel correlation tests as implemented in the
isolation-by-distance (IBD) web service (http://ibdsw.sdsu.
edu/,ibdws/) [42]. Matrices of geographical distances
Figure 1. Geographic location of HIV-1B polp sequences used in this study. Map shows the countries for which available sequences from
HIV-1B infected patients were available (colored), and the number of sequences per country (n). Insert at the top right shows an expansion of the
Eastern Caribbean islands. All sequences were sampled between 1996 and 2010.
doi:10.1371/journal.pone.0069218.g001
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between pairs of countries were obtained by using GenAlEx6
[43], and matrices of genetic distances were obtained using
MEGA 5 [38]. Geographic and genetic distances between
pairs of populations were log transformed, and 1000
permutations were carried out to assess the significance of
the correlations.
Reconstruction of Spatio-temporal Dynamics
In order to know how HIV-1B has spread across Central
American and Caribbean countries, the spatial dynamics of the
virus populations through time were reconstructed for both
regions using two different approaches:
1)) We performed Population Graphs analyses [44] to represent
relations among populations. Population Graphs use distances
between individuals or populations to construct a network of
nodes, which diameter represents the within-population
genetic diversity, and edges linking the nodes that are
proportional to population co-variances. The resulting
network leaves populations with an independent structure
unconnected. This method is nonhierarchical and allows for
reticulate relationships.
2)) We employed a model of discrete diffusion in a Bayesian
inference framework as implemented in BEAST v1.6.1 [19].
This approach draws an explicit model describing how HIV-
1B lineages, represented by the sampled sequences, migrated
during their evolution across countries. The methodology
employs continuous-time Markov chain models of discrete
state evolution (meaning that rather than the individual GPS
coordinates of each sequence being considered, all the
sequences from the same country were assigned the same
country state) to achieve ancestral reconstruction of these
states. Inference of geographical locations throughout the
evolutionary history along with a statistically meaningful
measure of the confidence that can be associated with
epidemiological linkage is achieved by using Bayes factors
(BF) [45]. By connecting a stochastic model of discretized
diffusion to standard models of sequence evolution, this
method fully accounts for the uncertainty of every aspect in
the underlying phylogeographic process [19]. Importantly,
Population Graphs only take into account polymorphic sites,
while Bayesian reconstructions use the whole sequence. The
MCC trees for each data set were annotated with country
state using the software TreeAnnotator (available in BEAST
package). The tools available from http://beast.bio.ed.ac.uk/
Google_Earth were used to produce a graphical representa-
tion of the spatio-temporal movement dynamics of ancestral
HIV-1B sequences.
Statistical Analysis
To discard that our substitution rate and TMRCA estimates
could be biased due to either over- or under-representation of
some countries, we performed BEAST analysis using a subset of
sequences containing between 4 and 15 sequences per country
(‘‘balanced’’ subsets) in both the Central American and the
Caribbean data sets. Thus, all sequences from countries with less
than 15 polp sequences were kept, and for countries with more than
this number, fifteen sequences were randomly chosen. This
randomization was repeated ten times and nucleotide substitution
rates and TMRCAs were estimated in the ten ‘‘balanced’’ subsets.
We analyzed the correlation between the genetic diversity of the
HIV-1B population in each country and the corresponding virus
prevalence using Pearson’s correlation test. The presence of
outliers, which potentially prevent significant linear correlation,
was detected by calculating the studentized residual for each data
point, dividing the residual by its standard deviation. Values
outside the 95% CI of the Student t test distribution drawn with all
of the studentized residuals were considered outliers. Statistical
analyses were performed using SPSS 17.0 (SPSS Inc., Chicago,
USA).
Results
Rapid Evolutionary Rates of the HIV-1B Populations in
Central America and The Caribbean
Our analyses revealed significant root-to-tip correlations of
sampling time vs. genetic distance for both the Central American
(r = 0.42; P = 161025) and the Caribbean (r = 0.30; P = 161025)
data sets (Figure S1). Therefore, the two polp data sets contained
sufficient temporal structure for reliable estimation of evolutionary
rates and divergence times of the HIV-1B populations. This was
confirmed by the significantly smaller mean and larger HPDs of
the substitution rate estimates obtained for randomized data sets as
compared with those from the real data (data not shown). Root-to-
tip correlations considering the sequences of each country
individually showed non-significant values in 4/5 and 10/13
countries in Central America and The Caribbean, respectively,
plus no differences in rate estimates between real and randomized
data sets. This prevented obtaining nucleotide substitution rates
for the HIV-1B populations in most countries (see Table 1).
Estimated nucleotide substitution rates for the Central Amer-
ican and Caribbean data sets revealed similar mean values:
3.8961023 subs/site/year (95% HPD = 2.8961023 to
4.7261023) for the Central American population, and
3.5961023 subs/site/year (95% HPD = 3.0361023 to
4.2461023) for the Caribbean population (Table 1). The results
from the ‘‘balanced’’ data sets did not differ from those obtained
considering the complete data sets (Table S2). Hence, the HIV-1B
populations in Central America and The Caribbean evolve
rapidly, with no apparent effect of geographical location in their
substitution rates.
Age of HIV-1B Epidemic in The Caribbean and in Central
America
TMRCA estimates indicated that the HIV-1B sampled diversity
arose around 1990 in Central America (95% HPD = 1985–1996),
and around 1980 in The Caribbean (95% HPD = 1960–1986).
Therefore, our most conservative estimates indicate that the HIV-
1B epidemic started not earlier than the 80 s in Central America,
and not before 1960 in The Caribbean. Importantly, estimates of
the ‘‘balanced’’ data sets yielded similar results (Table S2). Our
results indicated that the HIV-1B epidemic in Central America
seemed to have started earlier in Honduras (1990; 95%
HPD = 1985–1996) than in Panama, El Salvador, and Mexico
(1994–1996; 95% HPD = 1984–1998), with the most recent
introduction occurring in Belize (1998; 95% HPD = 1990–2000).
In The Caribbean, our TMRCA estimates indicated that the
earliest epidemic occurred in the islands of Puerto Rico and
Antigua (1980; 95% HPD = 1960–1986), and the latest in
Dominica (1987; 95% HPD = 1984–1990), with the HIV-1B
populations in the rest of the countries showing TMRCAs within
this interval of seven years (Table 1). These values were not
significantly different from those obtained for the countries for
which TMRCAs could be estimated independently, thus validat-
ing our approach (not shown). Therefore, the HIV-1B epidemic
seems to have started earlier in The Caribbean than in Central
HIV Phylogeography in Caribbean/Central America
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America, rapidly spreading between countries in both geograph-
ical regions (within a decade after the first introduction).
Phylogenetic Clustering of HIV-1B Sequences in Central
America and The Caribbean
Visual inspection of our MCC trees suggested a certain degree
of genetic structure based on geographical location (Figure 2).
Accordingly, both the AI and PS statistics revealed a significant
association between the HIV-1B phylogeny and the country of
origin of the sequences across the whole Central American and
Caribbean phylogenies (P,161025). The MC statistic also
indicated a significant association for each country (P,0.05)
(Table 1 and Figure 2). In addition, the three statistics showed a
significant spatial genetic structure of the Caribbean population
according to whether each sequence was originated in the Greater
or Lesser Antilles (P,161023). This indicated the existence of two
Table 1. Nucleotide substitution rate and TMRCA estimates for the pol fragment of 1,610 sequences obtained from HIV-1 infected
patients from Centro-American and Caribbean countries.
Country na Date range Substitution Rateb MRCAc dd MCe
Prevalence
(%)f
First HIV
detectiong
Central America Honduras 568 2001–2010 4.0261023 (3.73–
4.6561023)
1990 (1985–
1996)
0.01860.000 161023 1.0 1985
Panama 134 2004–2005 ND 1994 (1984–
1998)
0.02060.001 161023 1.2 1984
El Salvador 17 2010 ND 1996 (1990–
1998)
0.03160.001 161023 0.8 1984
Mexico 46 2001–2005 ND 1996 (1990–
1998)
0.01560.001 161023 0.3 1983
Belize 9 2004 ND 1998 (1990–
2000)
0.02060.001 161023 2.3 1986
ALL 774 2001–2010 3.8961023 (2.89–
4.7261023)
1990 (1985–
1996)
0.02260.004 0.5
Caribbean Puerto Rico 276 1996–2005 2.8061023 (0.88–
4.7461023)
1980 (1960–
1986)
0.02860.001 161023 0.5* 1981
Antigua 8 2000 ND 1980 (1960–
1986)
0.02360.002 761023 0.7* 1985
Cuba 276 1999–2010 3.6461023 (1.07–
4.3061023)
1982 (1975–
1985)
0.03560.001 161023 0.1 1986
Jamaica 112 2001–2009 2.0361023 (0.87–
4.2361023)
1983 (1981–
1985)
0.03060.001 161023 1.8 1982
St. Lucia 4 2000 ND 1983 (1981–
1986)
0.01760.001 161023 0.1* 1985
Bahamas 14 2004 ND 1984 (1982–
1989)
0.04560.002 161023 3.1 1985
Grenada 4 2000 ND 1984 (1981–
1986)
0.00160.000 361023 - 1984
Barbados 24 1996 ND 1984 (1982–
1988)
0.02260.001 161023 1.0 1984
Haiti 20 2004–2005 ND 1985 (1983–
1987)
0.01160.001 0.05 2.3 1983
Dominican Republic20 2002–2005 ND 1985 (1980–
1990)
0.02660.001 161023 0.9 1983
Trinidad & Tobago 68 2000–2003 ND 1985 (1983–
1989)
0.02760.001 161023 1.4 1983
St. Vincent &
Grenadines
6 2000 ND 1985 (1983–
1990)
0.02360.003 361023 0.9* 1984
Dominica 4 2000 ND 1987 (1984–
1990)
0.02060.002 161023 0.4* 1987
ALL 836 1996–2010 3.5961023 (3.03–
4.2461023)
1980 (1960–
1985)
0.03560.004 1.0
aNumber of partial pol sequences of each country.
bNucleotide substitution rate (substitutions per site per year), with 95% HPD in parenthesis.
cMost Recent Common Ancestor (date) based on Figure 2 trees, with 95% HPD in parenthesis.
dGenetic distance (mean6standard error).
eMonophyletic clade size significance (p-value).
fMean prevalence of HIV-1 infection between 2001–2010 (UNAIDS 2010). Asterisks indicate data extracted from the OECS HIV-AIDS report 2006.
gYear in which first case of AIDS was reported.
ND: Not-determined due to lack of temporal structure in the data set.
doi:10.1371/journal.pone.0069218.t001
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major clusters: Cluster I, which grouped the majority of the
sequences from the Lesser Antilles, Haiti plus half of the Jamaican
sequences; and Cluster II, which included most of Greater Antilles
sequences (The Bahamas, Cuba, Puerto Rico, Dominican
Republic, and about half of the Jamaican sequences) (Figure 2B).
MCC trees obtained for the ‘‘balanced’’ subsets of sequences
presented similar distribution patterns (available upon request).
Hence, HIV-1B isolates coming from the same geographical area
tend to cluster together in the trees, indicating the existence of a
spatial genetic structure in the HIV-1B populations analyzed.
Genetic Differentiation of the Central American and
Caribbean HIV-1B Populations According to the Country
of Origin
Overall genetic diversities were generally very small in the HIV-
1B populations analyzed (Table 1), being significantly smaller in
the Central American than in the Caribbean population
(0.02260.004 vs. 0.03560.004, respectively). Overall HIV-1B
genetic diversities in each country were also generally smaller in
the Central American than in the Caribbean region, varying in a
2-fold interval for the former (0.01560.001 in Mexico to
0.03160.001 in El Salvador), and in a 4-fold interval for the later
(0.01160.001 in Haiti to 0.04560.002 in Bahamas). We excluded
Grenada whose low diversity value seemed to be due to the limited
number of sequences from this island (Table 1). These results
indicate that the polp region analyzed is subjected to strong
selective constraints to genetic change, higher in the Central
American than in the Caribbean population.
In addition, the mean within-country genetic diversity was
generally lower than the mean between-countries diversity in both
Central America (0.02160.003 vs. 0.02460.001; Table 2) and
The Caribbean (0.02460.003 vs. 0.03060.002; Table 3). Analysis
for each country showed a similar trend, with the exception of El
Salvador in Central America (Table 2), and Bahamas, Jamaica
and Cuba in The Caribbean (Table 3). The higher between-
countries genetic diversity observed in the two HIV-1B popula-
tions under study is indicative of spatial genetic structure
according to the country of origin. We validated these results by
Figure 2. Maximum clade credibility phylogenies of the HIV-1B populations. Trees for the Central American (A) and The Caribbean (B) HIV-1
sequences are based on a fragment of the pol gene (1,005 nt). Branch tip times reflect the times of viral sampling. The trees are automatically rooted
through the use of a relaxed molecular clock, and the total depth of the trees are the TMRCA of the HIV-1B Central American and Caribbean
populations. Asterisks indicate nodes with posterior probabilities of .0.80. Branches are colored based on the country state of each node inferred
using a discrete geographical model. Vertical back lines in panel B indicate the two mayor sequence clusters: I) Grouping sequences from the Eastern
Caribbean islands, Haiti plus half of the Jamaican sequences. II) Grouping sequences from the Western Islands: Cuban, Puerto Rican and Dominican
Republic, and half of the Jamaican and The Bahamas sequences.
doi:10.1371/journal.pone.0069218.g002
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calculating FST values using an AMOVA test, which showed a
significant degree of spatial genetic structure in both The
Caribbean (FST = 0.10; P = 1610
25) and Central America
(FST = 0.08; P = 1610
25). Interestingly, while the mean within-
country genetic diversity was similar in the Central American and
the Caribbean data sets, mean HIV-1B between-country genetic
diversity was higher in The Caribbean than in Central America.
This is suggestive of a higher degree of spatial structure in the
Caribbean area. Accordingly, NST values revealed higher degree of
spatial genetic structure based on the country of origin in The
Caribbean than in Central America (0.2860.11 vs. 0.1660.09,
respectively).
Finally, Mantel tests showed no significant correlation between
genetic and geographical distances among pairs of HIV-1B
populations (countries) in neither of the two data sets analyzed
(r = 0.36, P = 0.286 for Central America; r = 0.15, P = 0.806, for
The Caribbean).
Taken together, these results provide evidence of spatial genetic
structure in the Central American and the Caribbean HIV-1B
populations. To further analyze which factors may shape the
observed genetic structure, we analyzed the association between
virus prevalence and genetic diversity, as well as the spatio-
temporal dynamics of the HIV-1B populations in both regions.
Association between HIV-1B within-country Genetic
Diversity and Virus Prevalence in Central America and
The Caribbean
For Central America, no significant correlation was found
between HIV-1B within-country genetic diversity and prevalence
(r = 0.05; P = 0.942) (Table 1 and Figure 3). However, this was
solely due to the high genetic diversity of the virus population in El
Salvador as compared with its prevalence, which was detected as
an outlier of the distribution. When this country was eliminated
from the analysis, a significant positive correlation was found
between the two analyzed traits (r = 0.83; P = 0.045) (Figure 3). For
The Caribbean, mean HIV-1B prevalence could be obtained for
12/13 countries. Using this data, no significant correlation was
found between virus within-country genetic diversity and preva-
lence (r = 0.32; P = 0.304). Nevertheless, as for the Central
American data set, this was due to outlier values in Cuba and
Haiti. When these two countries were eliminated from the
analysis, again a significantly positive correlation between HIV-
1B genetic diversity and virus prevalence was found (r = 0.93;
P = 161024) (Figure 3).
Routes and Migration Patterns of HIV-1B Populations in
Central America and The Caribbean
The Population Graph constructed with the Central American
sequences showed connections between the countries in the central
region (Belize, Honduras and El Salvador), which were also
connected with the Northern and Southern countries. No
connection was found between Mexico and Panama, the two
more distant countries (Figure 4A). Interestingly, the most
important nodes in the network seemed to be Honduras and
Belize as they presented the highest number of connections, which
is suggestive of a stronger genetic flow in these countries. This was
in agreement with the higher within-country genetic diversity
(diameter of the nodes) in the central countries as compared with
Mexico and Panama, and with our calculated values of within-
country genetic diversity. HIV-1B populations from Honduras
and Belize seemed to be closer to those from Mexico (shorter
internode branches), which also suggests a more intense genetic
flow between the central and Northern areas (Figure 4A). The
Bayesian analysis was largely in accordance with Population
Graphs, revealing that HIV-1B seemed to have initially appeared
and spread within the central region (Honduras, El Salvador
BF.7), with later and simultaneous migrations from Mexico and
Panama (BF.17) to Honduras, El Salvador and Belize (BF.7),
and from El Salvador to Belize (BF = 6.6). Again, there was strong
evidence of genetic flow between Mexico, Honduras and Belize,
but no link between Mexico and Panama (Figure 4B and File S1).
Importantly, estimates of the ‘‘balanced’’ data sets yielded similar
results, with 7/10 replicates finding Honduras, and 3/10 finding
El Salvador, as the origin of the epidemic (Table S2). Together,
these results indicate that in Central America HIV-1B was
dispersed following a radial pattern.
For The Caribbean, Population Graphs showed a network
formed by most of the countries with the exception of Barbados
and Puerto Rico (Figure 4C). In agreement with our inferred
phylogeny, the Lesser Antilles (Antigua, Dominica, Grenade, St.
Lucia, St. Vincent, and Trinidad & Tobago), and the Greater
Antilles (Bahamas, Cuba, Dominican Republic, Haiti, Jamaica,
Puerto Rico) were significantly disconnected based on a binomial
test, forming two subgraphs (P,0.050 and P,0.033, respectively).
This indicates a higher genetic flow among closest countries than
among those separated by larger distances, and a clear East-West
division. Despite Barbados can be counted as part of the Lesser
Antilles, it seemed to be genetically disconnected from any other
country with the only exception of its association with Puerto Rico
(Figure 4C). The Bayesian reconstruction also indicated clearly
distinguishable migration areas within the Greater and within the
Table 2. Within- and between-country genetic distances for HIV-1 Centro-American populations.
Belize El Salvador Honduras Mexico Panama Total
Belize 0.02060.001
El Salvador 0.02760.001 0.03160.001
Honduras 0.02260.001 0.02660.001 0.01860.000
Mexico 0.02160.001 0.02560.001 0.02060.000 0.01560.001
Panama 0.02460.001 0.02960.001 0.02360.000 0.02260.000 0.02060.001
Within 0.02060.001 0.03160.001 0.01860.000 0.01560.001 0.02060.001 0.02160.003
Betweena 0.02460.001 0.02760.001 0.02360.001 0.02260.001 0.02560.002 0.02460.001
Between-country genetic diversities were obtained by pairwise comparisons. Diagonal values represent within-country genetic diversity. Values are mean6standard
deviation.
aMean between-countries genetic diversity calculated as the mean of pairwise comparisons for each country.
doi:10.1371/journal.pone.0069218.t002
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Lesser Antilles (Figure 4D and File S2). HIV-1B introduction in
these two areas seemed to have occurred through Puerto Rico,
with an early jump to Antigua (BF = 11.5) (Table 1 and Figure 2).
Based on our analysis, the spread of the virus could have occurred
in two waves. During the early 80 s the virus would have jumped
from Puerto Rico to Cuba and Haiti (BF.128), and from Antigua
to Bahamas, Jamaica and Haiti (BF between 4 and 25). In the
same period, a secondary dispersion event in the Greater Antilles
would have occurred between Haiti and Dominican Republic
(BF = 173). Meanwhile, in the Lesser Antilles the virus would have
jumped from Antigua to Trinidad and Tobago, Barbados and St.
Lucia (BF between 4 and 12). In a second wave during the late
80 s, the virus would have spread from Puerto Rico to Jamaica in
the Greater Antilles (BF = 4.5), and from Antigua to St. Vincent,
Dominica and Grenada in the Western Lesser Antilles (BF.4). It
is worth noting that at odds with the Population Graphs, Barbados
was included within the migration area of the Lesser Antilles, with
detectable migration events only with Antigua (Figure 2, Figure 4D
and File S2). Again, estimates of the ‘‘balanced’’ data sets yielded
similar results, and 8/10 replicates found Puerto Rico as the origin
of the epidemic (Table S2). Thus, HIV-1B spread in the
Caribbean islands seemed to have occurred mostly through
short-distance movements in two clearly distinguishable areas: one
in the Lesser Antilles following a North-South direction, and
another in the Greater Antilles following East-West diffusion.
Discussion
In this work we provide an analysis of the genetic structure and
the spatio-temporal dynamics of the HIV-1 subtype B populations
in Central America and The Caribbean. Both HIV-1B popula-
tions seems to be characterized by a recent origin, rapid
evolutionary dynamics, and are genetically structured according
to the country of origin. This genetic structure appears to be the
result of the virus dispersion pattern through short-distance
movements, and of a limited genetic flow between countries due
to geographical barriers and to preferential movement of human
populations among culturally related countries.
Our results are derived from both phylogenetic inferences based
on Coalescence Theory and from classical population genetics
analyses. By combining these two partially overlapping approach-
es, we have been able to obtain complementary information, as
well as to validate our results, which make our conclusions more
robust. In addition, the utilized data set (the largest at the time of
this study) included pol sequences from at least two thirds of the
countries in each of the two analyzed geographical regions.
Although the polp fragment is known to contain amino acid
positions associated with ARV resistance, which would potentially
bias our conclusions, the presence of drug resistance mutations has
been reported not to affect HIV-1 phylogenetic reconstructions
[22, 46]. Finally, although samples were collected along a
relatively short time span (10 to 14 years), this is in the same
Figure 3. Correlation between within-country genetic diversity and prevalence of HIV-1 in Central America and The Caribbean. Each
dot represents a country following the color codes in Figure 1. Grey dots indicate outlier countries eliminated from the analysis. Bottom maps show
the genetic diversity of each country (mean6standard deviation), with countries colored based on the prevalence of HIV-1 infection.
doi:10.1371/journal.pone.0069218.g003
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range than similar studies in other HIV-1 populations [25,47,48].
Moreover, by limiting our study to HIV-1 subtype B, the prevalent
HIV-1 variant in these countries; we have improved the accuracy
of our estimates of evolutionary parameters [49].
High Evolutionary Rates and Low Genetic Diversity in the
pol Gene
Estimates of evolutionary rates indicated rapid evolutionary
dynamics of the HIV-1B populations analyzed. These estimates
may be overestimates due to the short time span considered, and
to the presence of deleterious mutations still not purged by
selection, which seem to be a common component in intra-specific
analyses of evolutionary rates [50]. However, the inferred
substitution rates are within the range of those reported for other
HIV-1 populations around the world using equivalent fragment of
the pol gene [25,51,52,53]. The observed high evolutionary rates
were accompanied by a low genetic diversity in the polp fragment
(Table 1), indicating that this fragment is subjected to strong
selective constraints. This is not surprising since the RT and the PR
proteins are involved in vital functions for the virus life cycle such
as replication or infectivity [54]. In agreement with our results,
other studies have also found that the pol gene is highly conserved
[e.g. 55–57]. It is not obvious how high evolutionary rates and low
genetic diversity in the polp fragment coexist. It could be
hypothesized that this might be the result of multiple mutations
occurring in a reduced number of polymorphic sites [39]. Thus,
even with fast accumulation of mutations over time, nucleotide
changes between pairs of sequences would be located in just a few
sites, which would result in low pairwise genetic diversity. Indeed,
Figure 4. Genetic relations and representation of migration patterns of HIV-1B in Central America and The Caribbean. Genetic
relations are represented with Population Graphs, where diameter of the nodes represents the within-country genetic diversity of the viral
population. Edge length represents the among population genetic variation. No connectivity means no co-variation and therefore no genetic flow
between countries. Representations of migration routes between HIV-1B populations are presented as virus movements implied by country state
transitions along the branches of the MCC tree and are indicated using pink lines. Line colors indicate the overall Bayes Factor test support for
epidemiological linkage between countries, and arrows indicate the direction of the movement. Google Earth is the original source of these
representations. Original Google Earth images are accessible through Files S1 and S2. Each country is represented by a three-letter code. Central
America (Panels A and B): Belize-BEL, El Salvador-SAL, Honduras-HON, Mexico-MEX, and Panama-PAN. The Caribbean (Panels C and D): Antigua-ANT,
Bahamas-BAH, Barbados-BAR, Cuba-CUB, Dominica-DMN, Dominican Republic-RDM, Grenade-GRE, Haiti-HAI, Jamaica-JAM, Puerto Rico-PRC, St. Lucia-
STL, St. Vincent and the Grenadines-SVG, Trinidad and Tobago-TTB.
doi:10.1371/journal.pone.0069218.g004
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the RT and the PR proteins require full preservation of at least two
thirds of their sequence in order to remain functional [55,56].
The Caribbean and Central American HIV-1B Populations
are Genetically Structured According to the Country of
Origin
Phylogenetic trees and AMOVA analyses indicated that the
studied HIV-1B populations were genetically structured according
to the geographical location (country). Genetic bottlenecks during
transmission would generate the observed phylogenetic clustering
by two mechanisms: (i) Selective pressures exerted, for instance, by
the host’s immune system and/or ARV therapies would be
different in each country [57]. As a consequence, the more fit
HIV-1B variants would differ between countries, generating the
observed spatial structure. There are several arguments against
this idea. First, there is a lack of evidence of such differential
selection [12,16]. Second, strong pressures selecting for variants
with resistance to ARV drugs would have kept relatively constant
the genetic diversity of the virus population regardless of its
prevalence. That is, in spite of differences in the number of
infected individuals between countries, only a few variants
harboring drug resistance mutations would account for most of
the HIV-1B infections in each country. However, we observed a
positive correlation between genetic diversity and prevalence. (ii)
Effect of genetic drift [57]. Bottlenecks during horizontal
(individual to individual of the same generation) and vertical
(mother to child) transmission are a well-known feature of the HIV
pandemic [7,16]. Random transmission of HIV-1B variants due to
such bottlenecks during between-countries virus jump, and/or
during within-country virus transmission would have generated
the observed spatial genetic structure. Interestingly, the positive
association found between virus prevalence and population genetic
diversity, indicating that the higher the frequency of infected
individuals the higher the number of variants in the population,
supports the role of genetic drift in shaping the genetic structure of
the HIV-1B population in Central America and The Caribbean.
Previous analyses of the Caribbean and the Central American
HIV-1B populations have failed in finding sequence clustering
according to the country of origin [12,16,17], which is probably
due to the limited sample size used, both in terms of the number of
countries and of the number of sequences. Based on this result, it
has been proposed that the evolution of the Caribbean HIV-1B
population is driven by adaptation to the main transmission mode
rather than to genetic drift due to transmission bottlenecks [12].
Accordingly, the HIV-1B population from Latin America and The
Caribbean, which have different main transmission modes, seems
to be genetically different [17]. Although we found evidence of
genetic structure at the country level in the Caribbean HIV-1B
population, this is not incompatible with previous results. Rather,
selection for transmission mode and transmission bottlenecks
might be shaping the genetic structure of the virus population at
two different levels. Adaptation to transmission mode would act at
a larger inter-regional scale (i.e. geographical region scale), causing
the genetic differentiation of The Caribbean population from the
HIV-1B pandemic clade. Transmission bottlenecks would act at a
smaller intra-regional scale (i.e. country scale), causing the genetic
differentiation of the HIV-1B population between countries.
Remarkably, our between-countries FST values and those between
Latin American and Caribbean HIV-1B populations are in the
same range, suggesting that the strength of both forces in
generating the genetic spatial structure at the two spatial scales
could be similar.
It could be argued that our study does not take into account the
human collective from which sequences were obtained (i.e. infants
or adults; female sex workers or men who have sex with men, etc.).
Thus, the observed spatial structure might be just the consequence
of having different collectives sampled in different countries.
However, in the majority of the countries there were representa-
tives of two or more of these collectives. Moreover, sequences
within a given country did not generally group according to the
human collective sampled (not shown). Thus, it is unlikely that the
spatial genetic structure in the analyzed regions is an artifact.
HIV-1B Dispersion Pattern in Central America
In Central America, both the Population Graph and the
Bayesian phylogeographic reconstruction indicated that HIV-1B
seems to have arisen in the central area (Honduras), and spread to
the neighboring countries (El Salvador, Belize) through short-
distance movements. The epidemiological link between Honduras
and El Salvador is not surprising, since population movements
between these two countries has been constant since the early 20th
century [58]. During the 80 s, Salvadorans and Hondurans
emigrated northwards in great numbers. Although the destination
of most of them was Mexico and the US, Belize accepted many
migrants, especially from El Salvador [59], which would explain
the link between the HIV-1B populations of these two countries
(Figure 4B). Interestingly, Honduras, El Salvador and Belize seem
to have had secondary introductions both from North (Mexico)
and South (Panama) through long-distance radial movements.
This may reflect introductions from other geographical areas such
as North America and South America, perhaps associated with
emigrants returning to their countries. Reported evidence of the
link between the HIV-1B epidemics in the US and Mexico [60–
62], or between epidemics in Panama and South America [8],
would be compatible with this idea. Importantly, considering the
relative long period of asymptomatic infection of HIV-1B, we
should expect that the first AIDS reports must occurred around 8–
10 years later of the true TMRCAs. However, the year in which
the first HIV-1 case was reported in Honduras and Panama is in
the lower bound of the HPD interval of our estimated TMRCAs
[63] (Table 1), and for El Salvador, Belize and Mexico, TMRCA
estimates are slightly more recent than the first case reported [63]
(Table 1). Thus, we might be consistently underestimating
TMRCA values. This does not necessarily affect the observed
migration patterns, as the error is similar in all countries. TMRCA
underestimation is probably due to the short time span of our data
set rather than to a lack of sequence representativeness. Although
we cannot discard that the small number of sequences in some
countries does not reflect the genetic diversity of the virus
population, in most countries the calculated genetic diversity
matches what would be expected based on the virus prevalence,
suggesting that limited sample size might not have a great effect in
our reconstructions. Finally, the observed radial migration pattern
might also explain the absence of correlation between geographic
and genetic distances in our data set. The epidemic linkage
between distant locations may have disrupted this correlation.
HIV-1B Dispersion Pattern in The Caribbean
In The Caribbean, the Population Graph and the Bayesian
reconstruction detected two clearly distinguishable migration
areas, with little genetic exchange between them: one comprising
the Greater Antilles, and another including the Lesser Antilles.
This indicates that the dispersion of HIV-1B mainly occurred
through short-distance movements. Thus, geographic barriers to
virus movements seem to have played an important role in the
dispersion of the HIV-1B epidemic in The Caribbean.
Our phylogeographic reconstruction indicated that the HIV-1B
epidemic in The Caribbean could have been initially originated in
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Puerto Rico and Antigua, further spreading West and South. The
epidemiological link between these two islands is not unexpected
due to their geographical proximity, which makes Puerto Rico one
of the major destinations for Antiguan migrants. Puerto Rico and
the US have a shared HIV-1B epidemic [64], and it is believed
that the US was the origin of the Puerto Rican HIV-1B epidemic
[65]. However, there is no clear evidence supporting this idea. To
date, it is thought that the HIV-1B pandemic was originated in
Haiti in the 1960 s, when Haitian infected workers returned from
Africa [66]. Phylogenetic analyses based on the gag and env genes
have supported this idea [16]. Consequently, it could be assumed
that Haiti is the origin of the HIV-1B epidemic in The Caribbean.
However, other reposts have argued on a more recent introduc-
tion during the 80 s as a consequence of the sexual tourism from
the US [20,21]; and reconstructions of Caribbean HIV-1B
phylogenies based on the pol gene have indicated that the Haitian
sequences are not in the deepest branches of the tree [12]. Our
results are compatible with this second hypothesis, but do not
reject an initial introduction of HIV-1B in Haiti from Africa. It
might be possible that the introduction in Haiti in the 60 s resulted
in dead-end infections in The Caribbean islands, but succeeded
jumping to North America as suggested by Gilbert et al. [16].
Later, a second introduction from the US through Puerto Rico
during the 80 s, this time successful, would have generated the
epidemic in The Caribbean. Unfortunately, with the existing data
it is not possible to test this hypothesis, as pol sequences of the
oldest Haitian isolates are not available, and could not be
considered in our work. Analysis of HIV-1B dispersion patterns
using a data set including older pol Haitian and US sequences
would allow a fine time-scaled reconstructions of the epidemio-
logical links between the US and The Caribbean, which would
contribute to reconcile previous results and ours.
The reconstruction presented here has additional limitations:
the number of sequences from each country is highly variable. The
small sample size in some countries might not be representative of
the virus population, while large sequence numbers in other
countries may overweight their importance in the evolutionary
history of HIV-1B. This may impose a strong bias in our TMRCA
estimates and in the inferred migration routes. It is possible that we
could not reveal some epidemiological links and/or overrepre-
sented others. Indeed, in some countries the TMRCA values are
more recent than the first case reported. Although we cannot rule
out these factors as potential confounders, three lines of evidence
support at least in part our reconstruction. First, although most of
the genetic diversity of the HIV-1B population seems to have been
generated since the 80 s, our most conservative TMRCA estimates
trace the origin of the epidemic to the 60 s, in agreement with
previous results [16]. Second, reconstructions using the ‘‘bal-
anced’’ data sets, which contain a similar number of sequences per
country, are largely in agreement with results of the ‘‘unbalance’’
data set. Third, the reported date of the first HIV case in each
country falls within the HPD interval of our divergence time
estimates, and in many cases our most conservative estimates
(lower bound of the HPD) range between 3 and 10 years earlier
than the first reported case, in accordance with the HIV
asymptomatic period. Thus, our results generally match with the
known epidemiological history of the virus.
Regardless of the origin of the HIV-1B epidemic, it is worth
noting that we found an epidemiological link between Puerto Rico
and all the other Western islands that are considered Latin
American countries (Cuba, Haiti and Dominican Republic).
Similarly, the Antigua HIV-1B population was linked to all the
Eastern Caribbean islands, which were primarily ‘British-colo-
nized’. This may also explain the association of the Antiguan with
the Jamaican and Bahamas virus populations. Therefore, the
inferred HIV-1B migration patterns indicate that, besides geog-
raphy, cultural characteristics and migration patterns of the
human population are also relevant determinants of the virus
epidemiology and evolution in The Caribbean.
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